What is the price target for CHRD stock?
26 analysts have analysed CHRD and the average price target is 143.99 USD. This implies a price increase of 6.71% is expected in the next year compared to the current price of 134.93.
NASDAQ:CHRD • US6742152076
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHORD ENERGY CORP (CHRD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-31 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-03-27 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2026-03-24 | Truist Securities | Initiate | Buy -> Buy |
| 2026-03-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-03-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-03-05 | UBS | Maintains | Buy -> Buy |
| 2026-03-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-14 | Citigroup | Downgrade | Buy -> Neutral |
| 2026-01-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-09 | UBS | Maintains | Buy -> Buy |
| 2025-12-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-21 | William Blair | Initiate | Outperform |
| 2025-11-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-12 | UBS | Maintains | Buy -> Buy |
| 2025-10-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-14 | Roth Capital | Initiate | Buy |
| 2025-10-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.897B 6.85% | 5.251B 34.76% | 4.877B -7.12% | 4.805B -1.48% | 4.899B 1.96% | 5.216B 6.47% | 5.831B 11.79% | 5.773B -0.99% | |
| EBITDA YoY % growth | 1.875B -3.80% | 2.28B 21.63% | 2.208B -3.16% | 2.052B -7.06% | 2.278B 11.01% | 2.56B 12.38% | 2.472B -3.44% | 2.658B 7.52% | |
| EBIT YoY % growth | 1.276B -19.19% | 1.172B -8.12% | 737.814M -37.06% | 621.74M -15.73% | 752.37M 21.01% | 791.19M 5.16% | N/A | N/A | |
| Operating Margin | 32.74% | 22.32% | 15.13% | 12.94% | 15.36% | 15.17% | N/A | N/A | |
| EPS YoY % growth | 20.07 -28.58% | 16.68 -16.89% | 9.46 -43.29% | 5.19 -45.19% | 8.92 71.99% | 12.21 36.88% | 10.70 -12.31% | 14.22 32.83% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.90 -53.04% | 2.44 36.04% | 2.36 0.47% | 2.33 81.95% | 2.33 23.02% | 2.06 -15.44% | 2.36 -0.09% | 2.58 10.75% | 3.80 62.72% | 3.76 82.66% | 3.89 64.85% | 4.21 63.28% |
| Revenue Q2Q % growth | 1.143B -5.93% | 1.212B 2.66% | 1.201B -8.47% | 1.184B 1.25% | 1.18B 3.24% | 1.184B -2.31% | 1.222B 1.75% | 1.241B 4.81% | 1.244B 5.42% | 1.223B 3.29% | 1.244B 1.80% | 1.259B 1.45% |
| EBITDA Q2Q % growth | 555.99M -19.12% | 575.96M -33.52% | 581.25M -54.34% | 580.71M -62.77% | 597.76M 7.51% | 595M 3.31% | 622.43M 7.08% | 642.36M 10.62% | 666.72M 11.54% | 668.79M 12.40% | 676.65M 8.71% | 687.37M 7.01% |
| EBIT Q2Q % growth | 193.13M -42.79% | 226.72M 62.52% | 200.36M 17.06% | 216.15M 141.58% | 210.91M 9.21% | 196.89M -13.16% | 209.18M 4.40% | 229.19M 6.03% | 273.88M 29.86% | 243.19M 23.52% | 247.03M 18.09% | 264.36M 15.35% |
All data in USD
26 analysts have analysed CHRD and the average price target is 143.99 USD. This implies a price increase of 6.71% is expected in the next year compared to the current price of 134.93.
CHORD ENERGY CORP (CHRD) will report earnings on 2026-05-04, after the market close.
The consensus EPS estimate for the next earnings of CHORD ENERGY CORP (CHRD) is 1.9 USD and the consensus revenue estimate is 1.14B USD.
The consensus rating for CHORD ENERGY CORP (CHRD) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.